A pilot study with monosialoganglioside GM1 on acute cerebral ischemia
Giraldi, C.; Masi, M.C.; Manetti, M.; Carabelli, E.; Martini, A.
Acta Neurologica 12(3): 214-221
1990
ISSN/ISBN: 0001-6276 PMID: 2206015 Document Number: 348421
Reported here are the results of an open controlled study on the use of GM1 in cases of ischemic strokes in its acute phase. A statistically significant improvement was observed in cases treated with GM1 for neurological deficits (assessed by Mathew's rating scale, modified by Fritz-Werner) at 21, 60 and 120 days and for disability at 120 days.